DK0876491T3 - Langt QT-syndrom-gen, der koder for KVLQT1 og dets association med minK - Google Patents
Langt QT-syndrom-gen, der koder for KVLQT1 og dets association med minKInfo
- Publication number
- DK0876491T3 DK0876491T3 DK96946233T DK96946233T DK0876491T3 DK 0876491 T3 DK0876491 T3 DK 0876491T3 DK 96946233 T DK96946233 T DK 96946233T DK 96946233 T DK96946233 T DK 96946233T DK 0876491 T3 DK0876491 T3 DK 0876491T3
- Authority
- DK
- Denmark
- Prior art keywords
- long
- syndrome
- kvlqt1
- acid sequence
- mink
- Prior art date
Links
- 208000004731 long QT syndrome Diseases 0.000 title abstract 6
- 108010011185 KCNQ1 Potassium Channel Proteins 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241000772415 Neovison vison Species 0.000 title abstract 2
- 102000014021 KCNQ1 Potassium Channel Human genes 0.000 title 1
- 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 108091006146 Channels Proteins 0.000 abstract 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002547 new drug Substances 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1901495P | 1995-12-22 | 1995-12-22 | |
| US73938396A | 1996-10-29 | 1996-10-29 | |
| PCT/US1996/019917 WO1997023632A1 (fr) | 1995-12-22 | 1996-12-20 | GENE DU SYNDROME DU Q-T LONG CODANT KVLQT1 ET SON ASSOCIATION AVEC minK |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0876491T3 true DK0876491T3 (da) | 2009-07-06 |
Family
ID=26691739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96946233T DK0876491T3 (da) | 1995-12-22 | 1996-12-20 | Langt QT-syndrom-gen, der koder for KVLQT1 og dets association med minK |
Country Status (11)
| Country | Link |
|---|---|
| EP (3) | EP0870041B1 (fr) |
| JP (2) | JP3449419B2 (fr) |
| AT (2) | ATE427993T1 (fr) |
| AU (2) | AU714527B2 (fr) |
| CA (1) | CA2240737C (fr) |
| DE (2) | DE69636870T2 (fr) |
| DK (1) | DK0876491T3 (fr) |
| ES (1) | ES2325820T3 (fr) |
| NZ (2) | NZ330743A (fr) |
| PT (1) | PT876491E (fr) |
| WO (2) | WO1997023598A2 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274332B1 (en) * | 1995-12-22 | 2001-08-14 | Univ. Of Utah Research Foundation | Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| US6277978B1 (en) | 1995-12-22 | 2001-08-21 | University Of Utah Research Foundation | KVLQT1—a long QT syndrome gene |
| WO1999021875A1 (fr) | 1997-10-24 | 1999-05-06 | University Of Utah Research Foundation | Kncq2 et kncq3, genes du canal potassium ayant subi une mutation dans des convulsions neonatales familiales benignes (bfnc) et d'autres epilepsies |
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| EP1056765A4 (fr) * | 1998-02-25 | 2003-07-30 | Icagen Inc | Genes humains du canal potassique |
| US6071720A (en) | 1998-04-29 | 2000-06-06 | Incyte Pharmaceuticals, Inc. | Delayed rectifier potassium channel subunit |
| ATE342279T1 (de) * | 1999-01-26 | 2006-11-15 | Neurosearch As | Kaliumkanäle und für diese kaliumkanäle kodierende gene |
| US6794161B1 (en) | 1999-01-26 | 2004-09-21 | Neurosearch A/S | Potassium channels and genes encoding these potassium channels |
| AU779477B2 (en) * | 1999-08-09 | 2005-01-27 | University Of Utah Research Foundation | Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| AU7854900A (en) | 1999-10-08 | 2001-04-23 | Vanderbilt University | Method of screening for susceptibility to drug-induced cardiac arrhythmia |
| EP1176197A1 (fr) * | 2000-06-16 | 2002-01-30 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Modèle d'arythmies cardiaques utilisant des animaux transgéniques |
| AU8880701A (en) * | 2000-09-06 | 2002-03-22 | Univ Johns Hopkins | Cardiac arrhythmia treatment methods |
| US8013133B2 (en) | 2003-04-25 | 2011-09-06 | Medtronic, Inc. | Genetic modification of targeted regions of the cardiac conduction system |
| US10917454B1 (en) | 2019-08-01 | 2021-02-09 | Rohde & Schwarz Gmbh & Co. Kg | System and method for ATC voice quality assurance |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| CA1188246A (fr) | 1981-08-31 | 1985-06-04 | Jerry L. Gregory | Appareil de fermentation en continue contenant un microorganisme immobilise |
| US4868105A (en) | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5599673A (en) * | 1995-03-09 | 1997-02-04 | University Of Utah Research Foundation | Long QT syndrome genes |
-
1996
- 1996-12-20 DK DK96946233T patent/DK0876491T3/da active
- 1996-12-20 EP EP96945935A patent/EP0870041B1/fr not_active Expired - Lifetime
- 1996-12-20 AU AU17428/97A patent/AU714527B2/en not_active Expired
- 1996-12-20 ES ES96946233T patent/ES2325820T3/es not_active Expired - Lifetime
- 1996-12-20 DE DE69636870T patent/DE69636870T2/de not_active Expired - Lifetime
- 1996-12-20 WO PCT/US1996/019756 patent/WO1997023598A2/fr active IP Right Grant
- 1996-12-20 EP EP09156996A patent/EP2085478A1/fr not_active Withdrawn
- 1996-12-20 AT AT96946233T patent/ATE427993T1/de active
- 1996-12-20 NZ NZ330743A patent/NZ330743A/xx not_active IP Right Cessation
- 1996-12-20 NZ NZ330744A patent/NZ330744A/xx not_active IP Right Cessation
- 1996-12-20 EP EP96946233A patent/EP0876491B1/fr not_active Expired - Lifetime
- 1996-12-20 JP JP52372697A patent/JP3449419B2/ja not_active Expired - Lifetime
- 1996-12-20 CA CA002240737A patent/CA2240737C/fr not_active Expired - Lifetime
- 1996-12-20 PT PT96946233T patent/PT876491E/pt unknown
- 1996-12-20 AT AT96945935T patent/ATE352629T1/de not_active IP Right Cessation
- 1996-12-20 JP JP52370497A patent/JP2001519646A/ja not_active Ceased
- 1996-12-20 WO PCT/US1996/019917 patent/WO1997023632A1/fr not_active Application Discontinuation
- 1996-12-20 AU AU19512/97A patent/AU714041B2/en not_active Expired
- 1996-12-20 DE DE69637895T patent/DE69637895D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0870041A4 (fr) | 2002-01-23 |
| AU1742897A (en) | 1997-07-17 |
| CA2240737C (fr) | 2009-09-29 |
| NZ330744A (en) | 1999-02-25 |
| EP0876491B1 (fr) | 2009-04-08 |
| AU1951297A (en) | 1997-07-17 |
| DE69636870T2 (de) | 2007-11-08 |
| DE69636870D1 (de) | 2007-03-15 |
| ATE352629T1 (de) | 2007-02-15 |
| WO1997023632A1 (fr) | 1997-07-03 |
| JP2001519646A (ja) | 2001-10-23 |
| JP2001501445A (ja) | 2001-02-06 |
| EP2085478A1 (fr) | 2009-08-05 |
| DE69637895D1 (de) | 2009-05-20 |
| CA2240737A1 (fr) | 1997-07-03 |
| WO1997023598A2 (fr) | 1997-07-03 |
| EP0876491A1 (fr) | 1998-11-11 |
| EP0876491A4 (fr) | 2001-12-19 |
| ATE427993T1 (de) | 2009-04-15 |
| JP3449419B2 (ja) | 2003-09-22 |
| WO1997023598A3 (fr) | 1997-09-12 |
| ES2325820T3 (es) | 2009-09-18 |
| EP0870041A2 (fr) | 1998-10-14 |
| AU714041B2 (en) | 1999-12-16 |
| NZ330743A (en) | 1999-07-29 |
| EP0870041B1 (fr) | 2007-01-24 |
| AU714527B2 (en) | 2000-01-06 |
| PT876491E (pt) | 2009-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0876491T3 (da) | Langt QT-syndrom-gen, der koder for KVLQT1 og dets association med minK | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| PT991421E (pt) | Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa | |
| DE69510810D1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| ATE522621T1 (de) | Diagnose und behandlung von williams syndrom | |
| ATE419391T1 (de) | Gene und polypeptide in verbindung mit menschlichen pankreaskarzinomen | |
| DE69933998D1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| ATE131533T1 (de) | Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis | |
| DE68928728D1 (de) | Diagnose von retinoblastoma | |
| ES2168361T3 (es) | Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo. | |
| EE200100472A (et) | Polüpeptiid, antikehad, lahustuv polüpeptiid, polü- või oligonukleotiid ja meetod diferentsiaalseltekspresseerunud DNA järjestuste spetsiifiliseks identifitseerimiseks | |
| DK0697893T3 (da) | Nervetrådproteingenekspression og detektion af Alzheimers sygdom | |
| ATE534902T1 (de) | Replikationsproteinn ciz1 | |
| ATE387460T1 (de) | Verfahren und kit zur beurteilung des ausbruchs von rheumatoider arthritis | |
| ATE312914T1 (de) | Rdgb-proteine | |
| Clendenen | Whole-Exome Sequencing of a Family Quartet of Local Anesthesia Resistance | |
| Keating et al. | Long QT syndrome genes | |
| AU2020224073A8 (en) | Matrix extracellular phosphoglycoprotein (MEPE) variants and uses thereof | |
| DE69834831D1 (de) | Gen, das im zusammenhang steht mit gemütskrankheiten | |
| BR0204126A (pt) | Processo de identificação e investigação de deficiepi02041367ncias gênicas com utilização de fluorescência, ou processo pcr multiplex fluorescente |